Diversity and composition of gut microbiota in healthy individuals and patients at different stages of hepatitis B virus-related liver disease
暂无分享,去创建一个
Ming Wu | T. Tseng | J. Kao | Chun-Jen Liu | T. Su | Hung‐Chih Yang | Wei-Kai Wu | Chieh-Chang Chen | Chun-Ming Hong | Sih‐Han Liao | Shih-Jer Hsu | Meng-Ju Lin
[1] H. Tilg,et al. Gut-liver axis: Pathophysiological concepts and clinical implications. , 2022, Cell metabolism.
[2] A. Kurilshikov,et al. Environmental factors shaping the gut microbiome in a Dutch population , 2022, Nature.
[3] W. Shu,et al. Gut microbiota dysbiosis in patients with hepatitis B virus-related cirrhosis. , 2022, Annals of hepatology.
[4] A. Gasbarrini,et al. Fecal Microbiota Transplantation in Patients with HBV Infection or Other Chronic Liver Diseases: Update on Current Knowledge and Future Perspectives , 2021, Journal of clinical medicine.
[5] Hang Zhou,et al. The diagnostic potential of gut microbiome for early hepatitis B virus-related hepatocellular carcinoma , 2020, European journal of gastroenterology & hepatology.
[6] Chang-qing Yang,et al. Effect of Entecavir on the Intestinal Microflora in Patients with Chronic Hepatitis B: A Controlled Cross-Sectional and Longitudinal Real-World Study , 2020, Infectious Diseases and Therapy.
[7] Zhishuo Mo,et al. Potential role of intestinal microflora in disease progression among patients with different stages of Hepatitis B , 2020, Gut Pathogens.
[8] Huiping Yuan,et al. Gut bacteria Akkermansia is associated with reduced risk of obesity: evidence from the American Gut Project , 2020, Nutrition & Metabolism.
[9] K. Verbeke,et al. Short chain fatty acids in human gut and metabolic health. , 2020, Beneficial microbes.
[10] Gavin M Douglas,et al. PICRUSt2 for prediction of metagenome functions , 2020, Nature Biotechnology.
[11] Yuhuan Li,et al. Entecavir Therapy Reverses Gut Microbiota Dysbiosis Induced by Hepatitis B Virus Infection in a Mouse Model. , 2020, International journal of antimicrobial agents.
[12] Robert D. Stedtfeld,et al. Featured Gut Microbiomes Associated With the Progression of Chronic Hepatitis B Disease , 2020, Frontiers in Microbiology.
[13] A. de Gottardi,et al. The gut-liver axis in liver disease: pathophysiological basis for therapy. , 2020, Journal of hepatology.
[14] Q. Ou,et al. Gut microbiota dysbiosis in patients with hepatitis B virus–induced chronic liver disease covering chronic hepatitis, liver cirrhosis and hepatocellular carcinoma , 2020, Journal of viral hepatitis.
[15] A. Sanyal,et al. THE ROLE OF THE GUT MICROBIOTA IN LIVER DISEASE. , 2020, American journal of physiology. Gastrointestinal and liver physiology.
[16] Xue-Fang Peng,et al. The intestinal microbial community dissimilarity in hepatitis B virus-related liver cirrhosis patients with and without at alcohol consumption , 2019, Gut Pathogens.
[17] William A. Walters,et al. Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2 , 2019, Nature Biotechnology.
[18] E. Chuang,et al. Altered gut microbiota and inflammatory cytokine responses in patients with Parkinson’s disease , 2019, Journal of Neuroinflammation.
[19] Ting Zhang,et al. Akkermansia muciniphila is a promising probiotic , 2019, Microbial biotechnology.
[20] Austin D. Swafford,et al. Age- and Sex-Dependent Patterns of Gut Microbial Diversity in Human Adults , 2019, mSystems.
[21] Yewei Zhang,et al. Alteration in gut microbiota associated with hepatitis B and non-hepatitis virus related hepatocellular carcinoma , 2019, Gut Pathogens.
[22] M. Abecassis,et al. Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases , 2019, Clinical Liver Disease.
[23] M. Abecassis,et al. Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases , 2018, Hepatology.
[24] Justine W. Debelius,et al. The gut–liver axis and the intersection with the microbiome , 2018, Nature Reviews Gastroenterology & Hepatology.
[25] Ding‐Shinn Chen,et al. Acoustic Radiation Force Impulse US Imaging: Liver Stiffness in Patients with Chronic Hepatitis B with and without Antiviral Therapy. , 2018, Radiology.
[26] Paul J. McMurdie,et al. DADA2: High resolution sample inference from Illumina amplicon data , 2016, Nature Methods.
[27] T. Karlsen,et al. The gut microbial profile in patients with primary sclerosing cholangitis is distinct from patients with ulcerative colitis without biliary disease and healthy controls , 2016, Gut.
[28] R. Talukdar,et al. Role of the normal gut microbiota. , 2015, World journal of gastroenterology.
[29] E. Goldstein,et al. Lactobacillus species: taxonomic complexity and controversial susceptibilities. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[30] B. Autran,et al. Towards an HBV cure: state-of-the-art and unresolved questions—report of the ANRS workshop on HBV cure , 2015, Gut.
[31] W. D. de Vos,et al. The first 1000 cultured species of the human gastrointestinal microbiota , 2014, FEMS microbiology reviews.
[32] B. Chassaing,et al. Microbiota‐liver axis in hepatic disease , 2014, Hepatology.
[33] W. Liu,et al. Abnormal fecal microbiota community and functions in patients with hepatitis B liver cirrhosis as revealed by a metagenomic approach , 2013, BMC Gastroenterology.
[34] Susan Holmes,et al. phyloseq: An R Package for Reproducible Interactive Analysis and Graphics of Microbiome Census Data , 2013, PloS one.
[35] Baoli Zhu,et al. Characterization of fecal microbial communities in patients with liver cirrhosis , 2011, Hepatology.
[36] C. Huttenhower,et al. Metagenomic biomarker discovery and explanation , 2011, Genome Biology.
[37] Wei Xu,et al. Intestinal Microbiota Was Assessed in Cirrhotic Patients with Hepatitis B Virus Infection , 2011, Microbial Ecology.
[38] Harry J. Flint,et al. Diversity, metabolism and microbial ecology of butyrate-producing bacteria from the human large intestine. , 2009, FEMS microbiology letters.
[39] J. Söderholm,et al. The role of microbiota and probiotics in stress-induced gastro-intestinal damage. , 2008, Current molecular medicine.
[40] A. Plebani,et al. Intestinal bacteria trigger T cell-independent immunoglobulin A(2) class switching by inducing epithelial-cell secretion of the cytokine APRIL. , 2007, Immunity.
[41] Hilde van der Togt,et al. Publisher's Note , 2003, J. Netw. Comput. Appl..
[42] Susumu Goto,et al. KEGG: Kyoto Encyclopedia of Genes and Genomes , 2000, Nucleic Acids Res..